Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis
Joong‐Yang Cho(Inje University Ilsan Paik Hospital), Woojun Kim(National Cancer Center), Byung‐Jo Kim(Korea University), Su‐Hyun Kim(National Cancer Center), Nam‐Hee Kim(Korea National Institute of Health), Ho Jin Kim(National Cancer Center), Suk-Won Ahn(Chung-Ang University Hospital), Min Su Park(Yeungnam University College), Ju‐Hong Min(Samsung Medical Center), Jae-Young An(The Catholic University of Korea St. Vincent's Hospital), Keun‐Sik Hong(Inje University Ilsan Paik Hospital)
Cited by 8
Related Papers
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722
Neuromyelitis optica
|Nature Reviews Disease Primers|2020|464
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
Statins in Acute Ischemic Stroke: A Systematic Review
|Journal of Stroke|2015|146